Although that pivotal issue should not be overlooked in this paper, a significant part of it was already covered by others in reviews on roles of integrin-linked kinase in tumor signaling [158] and its perspectives as a therapeutic target [40, 153, 155, 157, 158, 222] or referring to specific types of cancers: hormonal [223], breast [224] or rhabdomyosarcoma [225]. This evidence concerns the gene ILK and cancer.